Acadia Can’t Slip Investor Suit Over Parkinson’s Drug Deaths

Acadia Can’t Slip Investor Suit Over Parkinson’s Drug Deaths
Acadia Pharmaceuticals escaped part of the securities fraud claims lodged in a proposed class action over its alleged cover-up of fatality risks associated with its Parkinson's disease treatment, but ... read more
Source: Bing NewsPublished on 2020-06-02